| __timestamp | Jazz Pharmaceuticals plc | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 90480000 |
| Thursday, January 1, 2015 | 449119000 | 133384000 |
| Friday, January 1, 2016 | 502892000 | 179997000 |
| Sunday, January 1, 2017 | 544156000 | 220119000 |
| Monday, January 1, 2018 | 683530000 | 258528000 |
| Tuesday, January 1, 2019 | 736942000 | 198205000 |
| Wednesday, January 1, 2020 | 854233000 | 181022000 |
| Friday, January 1, 2021 | 1451683000 | 198359000 |
| Saturday, January 1, 2022 | 1416967000 | 208789000 |
| Sunday, January 1, 2023 | 1343105000 | 211124000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals and medical devices, understanding financial trends is crucial. Jazz Pharmaceuticals plc and MiMedx Group, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Jazz Pharmaceuticals saw a staggering 230% increase in their Selling, General, and Administrative (SG&A) expenses, peaking in 2021. This growth reflects their aggressive expansion and investment in market presence. In contrast, MiMedx Group, Inc. experienced a more modest 133% rise in SG&A expenses, indicating a steady but cautious approach to scaling operations.
Jazz Pharmaceuticals' expenses surged notably in 2021, reaching their highest point, while MiMedx maintained a more consistent trajectory. These trends highlight differing strategic priorities and market responses, offering valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
BeiGene, Ltd. and MiMedx Group, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
Comparing SG&A Expenses: Alkermes plc vs MiMedx Group, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Perrigo Company plc or MiMedx Group, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Vericel Corporation vs MiMedx Group, Inc. Trends and Insights